These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34544617)

  • 21. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
    Idzerda L; Rader T; Tugwell P; Boers M
    J Rheumatol; 2014 May; 41(5):986-93. PubMed ID: 24584917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders.
    Ramiro S; Page MJ; Whittle SL; Huang H; Verhagen AP; Beaton DE; Richards P; Voshaar M; Shea B; van der Windt DA; Kopkow C; Lenza M; Jain NB; Richards B; Hill C; Gill TK; Koes B; Foster NE; Conaghan PG; Smith T; Malliaras P; Roe Y; Gagnier JJ; Buchbinder R
    J Rheumatol; 2019 Aug; 46(8):969-975. PubMed ID: 30709947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative.
    Antony A; Holland R; D'Agostino MA; Maksymowych WP; Bertheussen H; Schick L; Goel N; Ogdie A; Orbai AM; Højgaard P; Coates LC; Strand V; Gladman DD; Christensen R; Leung YY; Mease P; Tillett W
    Semin Arthritis Rheum; 2021 Apr; 51(2):367-386. PubMed ID: 33601193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updating the OMERACT filter: core areas as a basis for defining core outcome sets.
    Kirwan JR; Boers M; Hewlett S; Beaton D; Bingham CO; Choy E; Conaghan PG; D'Agostino MA; Dougados M; Furst DE; Guillemin F; Gossec L; van der Heijde DM; Kloppenburg M; Kvien TK; Landewé RB; Mackie SL; Matteson EL; Mease PJ; Merkel PA; Ostergaard M; Saketkoo LA; Simon L; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2014 May; 41(5):994-9. PubMed ID: 24634204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.
    Petkovic J; Barton JL; Flurey C; Goel N; Bartels CM; Barnabe C; de Wit MPT; Lyddiatt A; Lacaille D; Welch V; Boonen A; Shea B; Christensen R; Maxwell LJ; Campbell W; Jull J; Toupin-April K; Singh JA; Goldsmith CH; Sreih AG; Pohl C; Hofstetter C; Beaton DE; Buchbinder R; Guillemin F; Tugwell PS
    J Rheumatol; 2017 Nov; 44(11):1727-1733. PubMed ID: 28202740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updating the OMERACT filter: implications for imaging and soluble biomarkers.
    D'Agostino MA; Boers M; Kirwan J; van der Heijde D; Østergaard M; Schett G; Landewé RB; Maksymowych WP; Naredo E; Dougados M; Iagnocco A; Bingham CO; Brooks PM; Beaton DE; Gandjbakhch F; Gossec L; Guillemin F; Hewlett SE; Kloppenburg M; March L; Mease PJ; Moller I; Simon LS; Singh JA; Strand V; Wakefield RJ; Wells GA; Tugwell P; Conaghan PG
    J Rheumatol; 2014 May; 41(5):1016-24. PubMed ID: 24584916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.
    Holland R; Tillett W; Ogdie A; Leung YY; Gladman DD; Callis Duffin K; Coates LC; Mease PJ; Eder L; Strand V; Elmamoun M; Højgaard P; Chau J; de Wit M; Goel N; Lindsay CA; FitzGerald O; Shea B; Beaton D; Orbai AM
    J Rheumatol Suppl; 2018 Jun; 94():17-25. PubMed ID: 29858348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.
    Chiarotto A; Kaiser U; Choy E; Christensen R; Conaghan PG; Cowern M; Gill M; de Wit M; Gargon E; Horgan B; Kirkham JJ; Simon LS; Singh JA; Tugwell P; Turk DC; Mease PJ
    J Rheumatol; 2019 Oct; 46(10):1355-1359. PubMed ID: 30936284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set.
    Tieu J; Cheah JT; Black RJ; Christensen R; Ghosh N; Richards P; Robson J; Shea B; Simon LS; Singhi JA; Tugwell P; Boers M; Garibay MAA; Campochiaro C; Decary S; de Witt M; Fernandez AP; Keen HI; King L; Hinojosa-Azaola A; Hofstetter C; Gaydukova I; George MD; Gupta L; Lyne S; Makol A; Mukhtyar C; Oo WM; Petri M; Pisaniello HL; Sattui SE; Russell O; Teixeira V; Toupin-April K; Uhunmwangho C; Whitstock M; Yip K; Mackie SL; Goodman SM; Hill CL
    Semin Arthritis Rheum; 2021 Oct; 51(5):1139-1145. PubMed ID: 34253398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.
    Boers M; Idzerda L; Kirwan JR; Beaton D; Escorpizo R; Boonen A; Magasi S; Sinha I; Stucki G; Tugwell P
    J Rheumatol; 2014 May; 41(5):978-85. PubMed ID: 24584922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Report from the OMERACT Hand Osteoarthritis Working Group: Set of Core Domains and Preliminary Set of Instruments for Use in Clinical Trials and Observational Studies.
    Kloppenburg M; Bøyesen P; Visser AW; Haugen IK; Boers M; Boonen A; Conaghan PG; Hawker GA; Kvien TK; Landewé R; Uhlig T; Smeets W; Greibrokk E; van der Heijde DM
    J Rheumatol; 2015 Nov; 42(11):2190-7. PubMed ID: 26136489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Final Core Domain Set for Total Hip and Total Knee Replacement Trials for Endstage Arthritis.
    Singh JA; Dowsey MM; Dohm M; Goodman SM; Leong AL; Scholte Voshaar MMJH; Choong PF
    J Rheumatol; 2017 Nov; 44(11):1723-1726. PubMed ID: 28089984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.
    Beaton DE; Dyer S; Boonen A; Verstappen SM; Escorpizo R; Lacaille DV; Bosworth A; Gignac MA; Leong A; Purcaru O; Leggett S; Hofstetter C; Peterson IF; Tang K; Fautrel B; Bombardier C; Tugwell PS
    J Rheumatol; 2016 Jan; 43(1):214-22. PubMed ID: 26329339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.
    Décary S; de Wit M; Naye F; Barton JL; Fraenkel L; Li LC; Brooks P; Stacey D; Maxwell LJ; Campbell W; Hofstetter C; Voshaar M; Meara A; Christensen R; Boonen A; Suarez-Almazor ME; Meade T; March L; Jull JE; Alten R; Morgan EM; Stewart Hazlewood G; Barber CEH; Guillemin F; El-Miedany Y; Mittoo S; Robertson TW; Bartlett SJ; Singh JA; Mannion M; Nasef SI; Boel A; Adebajo A; Arnaud L; Gill TK; Moholt E; Burt J; Jayatilleke A; Hmamouchi I; Berthelsen DB; Blanco FJ; Mather K; Maharaj A; Sharma S; Caso F; Beaton D; Shea B; Fong C; Fernandez AP; Mackie S; Nikiphorou E; Jones A; Greer-Smith R; Sloan VS; Akpabio A; Strand V; Lee RR; Umaefulam V; Monti S; Abaza N; Schultz G; Stones S; Gossec L; Nielsen SM; Cavallo S; Srinivasalu H; Constien D; Evans V; Tugwell P; Toupin-April K
    Semin Arthritis Rheum; 2024 Apr; 65():152381. PubMed ID: 38306813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.
    Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH
    J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.
    Boers M; Beaton DE; Shea BJ; Maxwell LJ; Bartlett SJ; Bingham CO; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March L; Simon LS; Singh JA; Strand V; Wells GA; Tugwell P
    J Rheumatol; 2019 Aug; 46(8):1021-1027. PubMed ID: 30770515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
    Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
    J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.
    Toupin-April K; Barton JL; Fraenkel L; Meara A; Li LC; Brooks P; de Wit M; Stacey D; Légaré F; Shea B; Lyddiatt A; Hofstetter C; Christensen R; Scholte Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Karuranga S; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Beaton D; El-Miedany Y; Mittoo S; Bartlett SJ; Singh JA; Tugwell PS
    J Rheumatol; 2019 Oct; 46(10):1409-1414. PubMed ID: 30709963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.
    Toupin-April K; Décary S; de Wit M; Meara A; Barton JL; Fraenkel L; Li LC; Brooks P; Shea B; Stacey D; Légaré F; Lydiatt A; Hofstetter C; Proulx L; Christensen R; Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Guillemin F; Beaton D; El-Miedany Y; Mittoo S; Westrich Robertson T; Bartlett SJ; Singh JA; Mannion M; Nasef SI; de Souza S; Boel A; Adebajo A; Arnaud L; Gill TK; Moholt E; Burt J; Jayatilleke A; Hmamouchi I; Carrott D; Blanco FJ; Mather K; Maharaj A; Sharma S; Caso F; Fong C; Fernandez AP; Mackie S; Nikiphorou E; Jones A; Greer-Smith R; Sloan VS; Akpabio A; Strand V; Umaefulam V; Monti S; Melburn C; Abaza N; Schultz K; Stones S; Kiwalkar S; Srinivasalu H; Constien D; King LK; Tugwell P
    Semin Arthritis Rheum; 2021 Jun; 51(3):593-600. PubMed ID: 33892937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity.
    Tugwell P; Boers M; D'Agostino MA; Beaton D; Boonen A; Bingham CO; Choy E; Conaghan PG; Dougados M; Duarte C; Furst DE; Guillemin F; Gossec L; Heiberg T; van der Heijde DM; Hewlett S; Kirwan JR; Kvien TK; Landewé RB; Mease PJ; Østergaard M; Simon L; Singh JA; Strand V; Wells G
    J Rheumatol; 2014 May; 41(5):1000-4. PubMed ID: 24692531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.